BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 17317821)

  • 1. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma.
    Jia HL; Ye QH; Qin LX; Budhu A; Forgues M; Chen Y; Liu YK; Sun HC; Wang L; Lu HZ; Shen F; Tang ZY; Wang XW
    Clin Cancer Res; 2007 Feb; 13(4):1133-9. PubMed ID: 17317821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New genetic markers for diagnosis of hepatitis C related hepatocellular carcinoma in Egyptian patients.
    Saad Y; El-Serafy M; Eldin MS; Abdellatif Z; Khatab H; Elbaz T; Elgarem H
    J Gastrointestin Liver Dis; 2013 Dec; 22(4):419-25. PubMed ID: 24369324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression analysis for evaluation of potential biomarkers in hepatocellular carcinoma.
    Hass HG; Jobst J; Scheurlen M; Vogel U; Nehls O
    Anticancer Res; 2015 Apr; 35(4):2021-8. PubMed ID: 25862856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
    Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF
    Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
    Sun Y; Mi W; Cai J; Ying W; Liu F; Lu H; Qiao Y; Jia W; Bi X; Lu N; Liu S; Qian X; Zhao X
    J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
    Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T
    Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
    Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
    Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
    Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of MAGE-1, MAGE-3 and AFP mRNA as multimarker by real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma.
    Zhang Y; Li Q; Liu N; Song T; Liu Z; Guo R; Meng L
    Hepatogastroenterology; 2008; 55(88):2200-6. PubMed ID: 19260505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter.
    Tomizawa M; Yu L; Wada A; Tamaoki T; Kadomatsu K; Muramatsu T; Matsubara S; Watanabe K; Ebara M; Saisho H; Sakiyama S; Tagawa M
    Br J Cancer; 2003 Sep; 89(6):1086-90. PubMed ID: 12966430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma.
    Sato S; Genda T; Hirano K; Tsuzura H; Narita Y; Kanemitsu Y; Kikuchi T; Iijima K; Wada R; Ichida T
    Liver Int; 2012 Oct; 32(9):1382-90. PubMed ID: 22681639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution.
    Hsu HC; Cheng W; Lai PL
    Cancer Res; 1997 Nov; 57(22):5179-84. PubMed ID: 9371521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
    Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular background of alpha-fetoprotein in liver cancer cells as revealed by global RNA expression analysis.
    Saito S; Ojima H; Ichikawa H; Hirohashi S; Kondo T
    Cancer Sci; 2008 Dec; 99(12):2402-9. PubMed ID: 19038010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma.
    Shi M; Chen MS; Sekar K; Tan CK; Ooi LL; Hui KM
    Eur J Cancer; 2014 Mar; 50(5):928-36. PubMed ID: 24332572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma.
    Fatima S; Luk JM; Poon RT; Lee NP
    Expert Rev Mol Diagn; 2014 Jun; 14(5):535-48. PubMed ID: 24809435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC).
    Chen GG; Ho RL; Wong J; Lee KF; Lai PB
    Eur J Surg Oncol; 2007 Sep; 33(7):882-6. PubMed ID: 17433605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of α-fetoprotein and glypican-3 mRNAs in the peripheral blood of hepatocellular carcinoma patients by using multiple FQ-RT-PCR.
    Yan D; He Q; Chen Y; Wang L; Zhang X
    J Clin Lab Anal; 2011; 25(2):113-7. PubMed ID: 21438004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.